Abstract
Background. Asymptomatic esophagitis is not rare in gastroesophageal reflux disease. However, little attention has been given to this disease so far. We evaluated the clinical characteristics of patients with asymptomatic esophagitis and determined the factors associated with this disease. Methods. A cross-sectional survey was performed of 87 patients with esophagitis, aged 23 to 90 years, diagnosed by endoscopy. We assessed 12 clinical variables at the time of the endoscopy: symptoms, age, sex, severity of esophagitis (Los Angeles classification), grade of gastric mucosal atrophy, presence or absence of Barrett’s epithelium and sliding hernia, alcohol, smoking, body-mass index (BMI), comorbid diseases such as hypertension, diabetes and asthma, and medications such as calcium blocker and theophylline. Results. Most patients had grade A or B esophagitis; 64 patients were symptomatic, and the remaining 23 were asymptomatic. In a univariate analysis, the assessed variables sex, BMI, drinking, and smoking (habit and amount of consumption) were associated with asymptomatic esophagitis (P < 0.05). Then, multivariate logistic analysis performed using these four variables demonstrated that sex, BMI, and smoking (habit and number of cigarettes smoked daily) were significantly and in dependently associated with this disease (P < 0.05). Conclusions. Smoking, male sex, and lower BMI are independent factors associated with asymptomatic esophagitis. Since no information is available on the natural history of this disease, we should pay attention to patients with these characteristics.
Similar content being viewed by others
References
Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006;101:1900–20.
Ohara S, Kouzu T, Kawano T, Kusano M. Nationwide epidemiological survey regarding heartburn and reflux esophagitis in Japanese (in Japanese with English abstract). Nippon Shokakibyo Gakkai Zasshi (Jpn J Gastroenterol) 2005;102:1010–24.
Quigley EM. Non-erosive reflux disease: part of the spectrum of gastro-oesophageal reflux disease, a component of functional dyspepsia, or both? Eur J Gastroenterol Hepatol 2001;13 Suppl 1:S13–8.
El-Serag HB, Petersen NJ, Carter J, Graham DY, Richardson P, Genta RM, et al. Gastroesophageal reflux among different racial groups in the United States. Gastroenterology 2004;126:1692–9.
Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172–80.
Nandurkar S, Talley NJ. Barrett’s esophagus: the long and the short of it. Am J Gastroenterol 1999;94:30–40.
Fujiwara Y, Higuchi K, Shiba M, Watanabe T, Tominaga K, Oshitani N, et al. Association between gastroesophageal flap valve, reflux esophagitis, Barrett’s epithelium, and atrophic gastritis assessed by endoscopy in Japanese patients. J Gastroenterol 2003;38:533–9.
Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1969;3:87–97.
Fein M, Ritter MP, DeMeester TR, Oberg S, Peters JH, Hagen JA, et al. Role of the lower esophageal sphincter and hiatal hernia in the pathogenesis of gastroesophageal reflux disease. J Gastrointest Surg 1999;3:405–10.
Liu XH, Ke MY, Song ZQ, Luo JY, Yuan YZ, Hou XH, et al. The impact of rabeprazole treatment on the quality of life in patients with reflux esophagitis and non-erosive reflux disease. Zhonghua Nei Ke Za Zhi 2005;44:818–21.
Manabe N, Yoshihara M, Sasaki A, Tanaka S, Haruma K, Chayama K. Clinical characteristics and natural history of patients with low-grade reflux esophagitis. J Gastroenterol Hepatol 2002;17:949–54.
Spechler SJ, Jain SK, Tendler DA, Parker RA. Racial differences in the frequency of symptoms and complications of gastrooesophageal reflux disease. Aliment Pharmacol Ther 2002;16:1795–800.
Lasch H, Castell DO, Castell JA. Evidence for diminished visceral pain with aging: studies using graded intraesophageal balloon distension. Am J Physiol 1997;272:G1–3.
Johnson DA, Fennerty MB. Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease. Gastroenterology 2004;126:660–4.
Simons CT, Cuellar JM, Moore JA, Pinkerton KE, Uyeminami D, Carstens MI, et al. Nicotinic receptor involvement in antinociception induced by exposure to cigarette smoke. Neurosci Lett 2005;389:71–6.
Wewers ME, Dhatt RK, Snively TA, Tejwani GA. The effect of chronic administration of nicotine on antinociception, opioid receptor binding and met-enkephalin levels in rats. Brain Res 1999;822:107–13.
Paul RH, Brickman AM, Cohen RA, Williams LM, Niaura R, Pogun S, et al. Cognitive status of young and older cigarette smokers: data from the international brain database. J Clin Neurosci 2006;13:457–65.
Nguyen P, Lee SD, Castell DO. Evidence of gender differences in esophageal pain threshold. Am J Gastroenterol 1995;90:901–5.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nozu, T., Komiyama, H. Clinical characteristics of asymptomatic esophagitis. J Gastroenterol 43, 27–31 (2008). https://doi.org/10.1007/s00535-007-2120-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00535-007-2120-2